// STATE LEGISLATION TRACKER

Ohio SB 56: Revise medical and adult-use marijuana laws; levy marijuana taxes

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Ohio
Bill: SB 56
Session: 136
Filed: 2025-01-28
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Ohio SB56 revises Ohio's medical and adult-use marijuana laws, hemp rules, related criminal provisions, and marijuana tax structure. Based on the title, subjects, and status, it does not appear to directly affect compounded peptides, peptide prescribing, telehealth peptide care, NP or naturopathic scope, FDA 503A/503B compounding, or prescription monitoring for peptides.

Key Points

No clear change to compounded peptide access
No apparent change to off-label peptide prescribing
No apparent change to peptide telehealth rules
No apparent change to NP or naturopathic peptide scope
Controlled-substance changes appear marijuana-focused

What to Watch For

Note Cannabis-related controlled-substance edits should be checked before assuming they affect non-cannabis drugs.

Note Clinics offering both cannabis and peptide services may need separate compliance tracking.

Note No peptide compounding or FDA 503A/503B issue is visible from the available bill summary.

Where the Bill Stands

The bill was enacted with an effective date of March 20, 2026, with some provisions effective on other dates.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws